首页> 外国专利> COMPOSITION FOR PREVENTING OR TREATING DISEASES CAUSED BY OVER-EXPRESSION OF LXRΑ, CONTAINING LIQUIRITIGENIN OR ISOLIQUIRITIGENIN AS ACTIVE INGREDIENT

COMPOSITION FOR PREVENTING OR TREATING DISEASES CAUSED BY OVER-EXPRESSION OF LXRΑ, CONTAINING LIQUIRITIGENIN OR ISOLIQUIRITIGENIN AS ACTIVE INGREDIENT

机译:预防或治疗由LXRα过表达引起的疾病的组合物,其中包含异黄体生成素或异黄体生成素为有效成分

摘要

The present invention relates to a composition for preventing, relieving and treating diseases caused by expression or over-activation of liver X receptor α (LXRα) or sterol response element binding protein-1 (SREBP-1), containing liquiritigenin, isoliquiritigenin or a Glycyrrhizae Radix processed fraction extract containing the same as an active ingredient. The composition of the present invention can be effectively used to prevent, relieve and treat diseases such as fatty liver, hypertriglyceridemia, hyperreninemia, renin-induced hypertension, aldosteronism, adrenoleukodystrophy, glomerulosclerosis, proteinuria, renal failure, and the like. In addition, the composition of the present invention can be used to prevent and treat obesity.
机译:本发明涉及一种用于预防,缓解和治疗由肝X受体α(LXRα)或固醇响应元件结合蛋白-1(SREBP-1)的表达或过度激活引起的疾病的组合物,其包含liquiritigenin,isoliquiritigenin或 I>甘草提取物提取的馏分提取物,含有该提取物作为有效成分。本发明的组合物可以有效地用于预防,减轻和治疗诸如脂肪肝,高甘油三酯血症,高肾素血症,肾素诱导的高血压,醛固酮增多症,肾上腺神经营养不良,肾小球硬化,蛋白尿,肾衰竭等疾病。另外,本发明的组合物可以用于预防和治疗肥胖症。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号